Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for PMDI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
December 31, 2024 -0.886M
September 30, 2024 -0.294M
June 30, 2024 -0.134M
March 31, 2024 -0.075M
December 31, 2023 -0.073M
September 30, 2023 -0.074M
June 30, 2023 -0.928M
March 31, 2023 -0.072M
December 31, 2022 -0.582M
September 30, 2022 -0.568M
June 30, 2022 -0.60M
March 31, 2022 -0.174M
December 31, 2021 -0.515M
September 30, 2021 -0.177M
June 30, 2021 -0.172M
March 31, 2021 -0.171M
December 31, 2020 -0.172M
September 30, 2020 -0.169M
June 30, 2020 2.004M
March 31, 2020 -1.162M
December 31, 2019 0.321M
September 30, 2019 -1.098M
June 30, 2019 -1.13M
March 31, 2019 -1.095M
December 31, 2018 -2.023M
Date Value
September 30, 2018 -1.234M
June 30, 2018 -1.319M
March 31, 2018 -1.063M
December 31, 2017 1.084M
September 30, 2017 -0.926M
June 30, 2017 -2.509M
March 31, 2017 -1.105M
December 31, 2016 -2.663M
September 30, 2016 -1.254M
June 30, 2016 -1.400M
March 31, 2016 -0.6084M
December 31, 2015 -1.276M
September 30, 2015 -0.0648M
June 30, 2015 -1.208M
March 31, 2015 -1.156M
December 31, 2014 -1.210M
September 30, 2014 -0.1555M
June 30, 2014 4.056M
March 31, 2014 0.3025M
December 31, 2013 -0.8168M
September 30, 2013 -0.7847M
June 30, 2013 -0.902M
March 31, 2013 -0.7855M
December 31, 2012 -0.7895M
September 30, 2012 -0.7909M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Quest Diagnostics, Inc. -229.00M
Labcorp Holdings, Inc. -919.90M
OPKO Health, Inc. -13.03M
NeoGenomics, Inc. -12.24M
First Choice Healthcare Solutions, Inc. -0.14M